skip to main content

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

News

Clinical trial of innovative phage lysin HY-133 initiated
11.06.2024 Clinical trial of innovative phage lysin HY-133 initiated Press Release
"‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds"
04.06.2024 "‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds" In the Media

Forbes

"LuCa" project is funded by Else Kröner-Fresenius Foundation
16.05.2024 "LuCa" project is funded by Else Kröner-Fresenius Foundation CMFI News

Events

tba
20.06.2024 tba 12:30 pm 2:00 pm Joint Microbiological Colloquium Annika Hausmann More
Shedding light on the “unknome”: Novel approaches to discover the functions of unknown proteins
11.07.2024 Shedding light on the “unknome”: Novel approaches to discover the functions of unknown proteins 12:30 pm 2:00 pm Joint Microbiological Colloquium Jörg Stülke More
Flavin-dependent decarboxylation of cysteine residues
18.07.2024 Flavin-dependent decarboxylation of cysteine residues 12:30 pm 2:00 pm Joint Microbiological Colloquium Thomas Kupke More
33

About the CMFI

The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases it also damages the microbiome as a whole. 

 

CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.

The Cluster of Excellence CMFI brings together researchers from different disciplines such as infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, and medical history and ethics. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.

The CMFI is one of more than 50 Clusters of Excellence funded by German federal and state governments as part of the Excellence Strategy to sustainably strengthen Germany as a center of science, improve its international competitiveness and make cutting-edge research at German universities visible. In addition to the University of Tübingen, the Max Planck Institute for Biology and the University Hospital Tübingen are involved in the CMFI.

More about the Research